Home › Castration-Resistant Prostatic Cancer › South Carolina › Myrtle Beach
Castration-Resistant Prostatic Cancer clinical trials in Myrtle Beach, SC
3 studies for Castration-Resistant Prostatic Cancer are looking for participants at sites in and around Myrtle Beach (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
RecruitingPhase 3
- Carolina Urologic Research Center, Myrtle Beach
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
RecruitingPhase 3
- Carolina Urologic Research Center, Myrtle Beach
A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
RecruitingPhase 1
- START Carolinas, Myrtle Beach
Castration-Resistant Prostatic Cancer trials in other cities
- Los Angeles, CA8 studies
- New York City, NY7 studies
- Seattle, WA6 studies
- Houston, TX6 studies
- Boston, MA5 studies
- Pittsburgh, PA4 studies
- Queens, NY4 studies
- Philadelphia, PA4 studies
- Mountain View, CA3 studies
- Cincinnati, OH3 studies
- Nashville, TN3 studies
- Baltimore, MD3 studies
Other studies in Myrtle Beach
- Prostate Cancer23 studies
- Bladder Cancer10 studies
- Non-Muscle Invasive Bladder Cancer9 studies
- Kidney Cancer (Renal Cell Carcinoma)6 studies
- Urothelial (Transitional Cell) Carcinoma5 studies
- Metastatic Cancer5 studies
- Cancer (all types)3 studies
- Carcinoma in Situ3 studies
- Type 2 Diabetes3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.